“Last week, I had the honor of participating in the first-ever New York BCI Symposium, a unique event that highlighted the growing interest in BCI technology. The symposium featured a diverse group of over thirty experts, including researchers, neurosurgeons, advocates, and government officials, attracting a large audience of attendees from various backgrounds.
The event, co-hosted by Mount Sinai BioDesign and the Department of Neurosurgery at the Icahn School of Medicine at the New York Academy of Medicine, covered a wide range of topics such as breakthrough methods, ethics, and research initiatives. Speakers from Mount Sinai showcased the hospital system’s commitment to neurotech innovation, positioning it as a leader in the field.
In addition to experts from New York hospitals, the symposium also welcomed participants from other cities, fostering collaboration and innovation in the BCI field. Dr. Joshua Bederson, the system chair of neurosurgery at Mount Sinai, played a key role in setting a tone of humility and collaboration throughout the event.
Two of the event’s sponsors, Synchron and Precision Neuroscience, presented different visions for the future of BCI technology. Synchron focused on speed and efficiency with their minimally invasive Stentrode, while Precision prioritized future potential with their thin film array. Both companies showcased the diverse and exciting possibilities of BCI technology.”